Cardlytics (CDLX) Tops Q2 EPS by 49c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.24), $0.49 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $76.7 million versus the consensus estimate of $69.11 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Worthington Industries (WOR) Misses Q4 EPS by 9c
• Morgan Stanley Starts OGE Energy (OGE) at Equalweight